Tigermed GM completes planned share reduction

Hangzhou Tigermed Consulting announced that its significant shareholder and general manager, Ms. Cao Xiaochun, has completed her share reduction plan, which commenced on July 28, 2025. Over the three-month period ending November 18, 2025, Ms. Cao reduced her holdings by 347,600 shares through concentrated bidding transactions.

The average sale price per share was 60.78 yuan, with transaction prices ranging from 59.90 yuan to 61.23 yuan. This reduction represents 0.0406% of the company's total share capital (excluding repurchased shares) and 0.0475% of its A-share capital.

Post-reduction, Ms. Cao's total holding in Tigermed stands at 51,314,174 shares, or 6.0007% of the total share capital. The company confirmed that the share reduction was in line with regulatory requirements and its pre-disclosure, without impacting the company's control or governance structure.